Thomas M. Gavin, C.O. BioConcepts, inc. Burr Ridge, Illinois, USA

61
Indications for Treatment and Outcomes Evaluation for the Orthotic Management of Idiopathic Scoliosis Thomas M. Gavin, C.O. BioConcepts, inc. Burr Ridge, Illinois, USA Musculoskeletal Biomechanics Laboratory. Veterans Administration Hospital, AOPA Seattle 2009

description

Indications for Treatment and Outcomes Evaluation for the Orthotic Management of Idiopathic Scoliosis. Thomas M. Gavin, C.O. BioConcepts, inc. Burr Ridge, Illinois, USA Musculoskeletal Biomechanics Laboratory. Veterans Administration Hospital, Hines, Illinois, USA. AOPA Seattle 2009. - PowerPoint PPT Presentation

Transcript of Thomas M. Gavin, C.O. BioConcepts, inc. Burr Ridge, Illinois, USA

Page 1: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Indications for Treatment and Outcomes Evaluation for the

Orthotic Management of Idiopathic ScoliosisThomas M. Gavin, C.O.

BioConcepts, inc. Burr Ridge, Illinois, USA

Musculoskeletal Biomechanics Laboratory.Veterans Administration Hospital, Hines, Illinois,

USAAOPA Seattle 2009

Page 2: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Timothy J. Newton, C.O.January 4th 1949-September 13th 2009

Page 3: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

SRS Definition of Terms

ACCEPTEDNOMENCLATURE FOR SPINAL RELATED CONDITIONS AND PROCEDURES RELATED TO SPINAL DEFORMITIES.

Page 4: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

IDIOPATHIC SCOLIOSIS

Page 5: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

ORTHOTIC TREATMENT FOR IDIOPATHIC SCOLIOSIS

Why use an orthosis? When do we use an orthosis? How does an orthosis work? How long should it be worn? Which orthosis should I use? Is part-time treatment effective? What is the chance of still needing

surgery after orthotic management?

Page 6: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

CURVE PATTERNS AND

MEASUREMENTS

Page 7: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 8: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Left Lumbar Curve

King Type I

Page 9: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Right Thoracic PrimaryLeft Lumbar CompensatoryCurves.

King Type II

Page 10: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

King Right Thoracic Curve

King Type III

Page 11: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Thoracolumbar CurveKing Type IV

Page 12: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Cob

b A

n gl e

51°

Page 13: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

A B C D E

A. 0 Rotation. Neutral. No Rotation.

B. +1 Rotation. Pedicle Towards Midline. Concave Direction.

C. +2 Rotation. Pedicle 2/3 to Midline.

D. +3 Rotation. Pedicle at Midline.

E. +4 Rotation. Pedicle Beyond Midline.

Vertebral Rotation.

Page 14: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Maturation and Development

Vertebral Ring Apophyses. Line of Risser. Development of Secondary

Sex Characteristics. Menarche. Growth Velocity.

Page 15: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

VERTEBRALRING APOPHYSES

Page 16: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

A B C

A. Ring Apophysis Begins To Form.

B. Ossification Complete, Not United With Body.

C. Ossified and United With Body. Mature.

Page 17: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

RISSER SIGN

Page 18: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Risser 1 = 25% Capping. Risser 2 = 50% Capping.Risser 3 = 75% Capping.Risser 4 = 100% Capping.Risser 5 = 100% Capping + Fusion.

Line Of Risser

Page 19: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 20: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 21: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 22: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

TANNER SIGNS

Page 23: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

5 Stages of Breast and Pubic Hair Development

Page 24: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

5 Stages of Genitalia and Pubic Hair Development

Page 25: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 26: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 27: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 28: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 29: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

MATURITY AT ORTHOSIS INITIATION AFFECTS

OUTCOMES

Page 30: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

From Bunch and Patwardhan: Scoliosis; Making Clinical Decisions. CV Mosby Company, 1989

Bracing initiated at 6- 18 months Premenarchal

Page 31: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

From Bunch and Patwardhan: Scoliosis; Making Clinical Decisions. CV Mosby Company, 1989

Bracing Initiated 6 Months Premenarchal to 6 Months Post Menarche

Page 32: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

From Bunch and Patwardhan: Scoliosis; Making Clinical Decisions. CV Mosby Company, 1989

Bracing Initiated 6-18 Months Post-Menarche

Page 33: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Determining Clinical Curve Stiffness.

Side Bending Correction of Each Curve.

Expressed As % Correction From Normal.

% Correction Thoracic: % Correction Lumbar = “Flexibility Index” As Reported by King Et Al.

Page 34: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

A. B. C.

A. Normal Coronal Alignment .

B. Right Side Bending. Primary Thoracic Curve Resists Corrective Forces.

C. Left Side Bending. Compensatory Lumbar Curve Corrects To Nearly 0°.

Page 35: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Biological Changes in Bone Morphology

Epiphyseal Growth Is Slowed When Epiphyses Are

Compressed.(Hueter-volkman Principle)

Page 36: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

HUETER-VOLKMAN WEDGING.

Concave Side Epiphysis Develops at a Slower Rate Than Convex Side Due to Compression.

Page 37: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Clinical Evaluation and Mechanism of Action

Orthoses must be designed and fitted to: Reduce Curve Maximally. Reduce Any Decompensation. Be Easily Adjusted. Keep Constant Force On Curves. Be As Comfortable As Possible.

Page 38: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 39: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 40: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 41: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA
Page 42: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

NATURAL HISTORY:

RISK OF CURVE PROGRESSION.

Page 43: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

CURVE PROGRESSION Age.

Older Children Are Less Likely to Progress at Curve Magnitudes That Are Progressive in Younger Children.

Magnitude. Larger Curves Are More “Unstable” Than

Smaller. Curve Pattern.

Thoracic and Double Primary Curves Progress Less Than Single Lumbar or Thoracolumbar Curves.

Page 44: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Risk of Progression by Risser Sign. Lonstein and Carlson 1984 JBJS

22%

1.6%

68 %

23 %

0%

10%

20%

30%

40%

50%

60%

70%

80%

5-19 deg. 20-29 deg.

% Progressed

Risser 0-1

Risser 2-4

Page 45: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Risk of Progression by Chronological Age.Lonstein and Carlson 1984 JBJS

45%

23%8%4%

100%

61%

37%

16%

0%

20%

40%

60%

80%

100%

5-19 deg 20-29 deg

% Progressed up to 10 yrs

11-12 yrs

13-14 yrs

15 and older

Page 46: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

LONG-TERM CURVE PROGRESSION. (Avg. F/U 40 Years Post Diagnosis) From Weinstein et. al. 1984 JBJS

0%

10%

29%

0%

10%

20%

30%

40%

50%

< 30 Deg 30-50 Deg 50-75 Deg

% Progressed

Page 47: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Weinstein Zavala and Ponsetti 1984 JBJS

68% progressed > 5 degrees. 37% progressed in last 10

years. (avg. F/U 40 years post diagnosis.)

Page 48: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

TREATMENT OUTCOME

EXPECTATIONS.

Page 49: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Moe and Kettleson. 1970 JBJS

169 Patients Treated With Milwaukee Brace.

23% Average Correction of Thoracic Curves Post-treatment.

18% Average Correction of Lumbar and Thoracolumbar Curves Post-treatment.

Short Term Results.

Page 50: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Carr et. al. JBJS 1980

Re-Reviewed Moe’s Patients From 1970. Reported on Late Losses of Correction. Showed Late Losses of Correction. Results Showed Residual Curves Still

Less Than Pre-orthosis Magnitude.

Page 51: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Residual Curve 5-Years Post-Treatment By Menarche Value at Initiation Of Orthosis.

Bunch and Patwardhan, Chapter 13, Scoliosis; Making Clinical Decisions. 1989.

63%

80%100%

0%10%20%30%40%50%60%70%80%90%

100%

18 - 6 Mo. Pre 6 Pre - 6 Post 6-18 Post

Residual Curve as % of Initial Curve

Page 52: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Surgical Rates Following Orthotic Treatment

Based on Initial Risser Sign. From: Milwaukee Brace Treatment Of Ais. Lonstein and Winter. JBJS 1994

32%

12%

45%

18%

0%

10%

20%

30%

40%

50%

60%

20-29 DEG 30-39 DEG

% of Patients Requiring Surgery After Orthotic Treatment

Risser 0 -1

Risser 2+

Page 53: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Bunch Reported Best Curve Reduction for Youngest Group

and Lonstein Reported Highest Surgical Rates for Youngest

Group?

Page 54: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Orthotic Outomes; Failure Boundary

Page 55: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

PART-TIME VERSUS

FULL-TIME

Page 56: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

49%60% 62%

91%99%

0%10%20%30%40%50%60%70%80%90%

100%

Control Charleston Brace 16-Hour TLSO 23-Hour TLSO 23 HourMilwaukee Brace

Weighted Mean Proportion Of Success

A META-ANALYSIS OF THE EFFICACY OF NONOPERATIVE TREATMENT FOR IDIOPATHIC SCOLIOSIS. Rowe et al. - J Bone and Joint Surgery [Am]. 79-A (5) 664-674, 1997.)

Page 57: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

A Comparison Between The Boston Brace And The Charleston Bending Brace In Adolescent Idiopathic Scoliosis.

Katz DE, Richards S, Browne RH, Herring JA. Spine, 22(12); 1302-1312 ,1997.

61%

41%

19%

31%

0%

20%

40%

60%

80%

Success (p=0.001) Surgery (p= 0.021)

Risser 0-1 Patients Only

BostonBrace

CharlestonBrace

Page 58: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Primary Goals. Correct Curves >50%. Maintain Correction Throughout Duration

of Wear. Address Psycho-social Issues. Fulltime Until Proven Otherwise. Maximal Comfort. Minimal Structure.

Page 59: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Summary Orthoses Must Improve Stability To Yield

Optimal Outcome!Optimizing Orthotic Treatment Requires; 1. Proper Patient Selection (Age, Magnitude,

Documented Progression). 2.Utilization of All Mechanisms of Action to

Improve Stability. 3. Frequent Follow-Up Adjustments To Restore

Orthosis to Optimal Fit and Function.

4. Sound Clinical Procedures!

Page 60: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

In-Orthosis Correction of the Curve Should Always Exceed 50%

Orthosis Should NOT Increase Decompensation.

When Curve Appears to Progress From “Best In Brace” Magnitude, Orthosis Should Be Adjusted To Restore Curve Reduction.

Weaning Should Be Gradual!

Summary

Page 61: Thomas M. Gavin, C.O. BioConcepts, inc.  Burr Ridge, Illinois, USA

Thank You For Your Attention!

www.orthotic.com